newborn
calf
gastrointestin
tract
steril
birth
day
age
coliform
lactobacilli
bifidobacteria
predomin
flora
fece
prewean
period
calv
suscept
diarrhea
lead
high
level
morbid
mortal
diarrhea
relat
decreas
benefici
microbiota
increas
coliform
count
fece
prebiot
supplement
believ
decreas
diarrhea
posit
affect
paramet
immun
system
calv
supplement
shown
promis
effect
intestin
microbi
popul
limit
inform
effect
immun
main
object
studi
evalu
effect
prebiot
supplement
contain
ferment
product
lactic
acid
bacteria
mucos
immun
system
measur
fecal
salivari
iga
evalu
calf
health
growth
perform
trial
holstein
calv
randomli
assign
receiv
milk
replac
prebiot
supplement
gday
prebio
meiji
feed
co
ltd
tokyo
japan
milk
replac
prebiot
control
fecal
salivari
iga
calf
health
plasma
igg
lymphocyt
count
affect
treatment
lactobacilli
count
fece
higher
p
bifidobacteria
tend
higher
p
calv
fed
prebiot
prebiot
supplement
increas
benefici
bacteria
calv
decreas
overal
incid
diarrhea
trial
calv
studi
affect
cryptosporidiosi
treat
antibiot
possibl
limit
effect
prebiot
product
fecal
iga
seem
good
measur
mucos
immun
studi
need
develop
method
measur
type
immun
calv
gastrointestin
tract
newborn
calv
steril
microb
introduc
environ
dam
birth
canal
colon
gastrointestin
tract
ewaschuk
et
al
ouwehand
et
al
day
birth
coliform
lactobacilli
bifidobacteria
predomin
flora
fece
ouwehand
et
al
et
al
howev
neonat
calf
microbi
popul
transit
extrem
sensit
sudden
chang
diet
environ
diseas
stress
caus
alter
krehbiel
et
al
ouwehand
et
al
microbi
system
newborn
calv
often
expos
high
level
stress
first
day
life
experi
chang
environ
diet
feed
condit
handl
immun
period
calv
develop
diarrhea
common
health
concern
caus
death
prewean
period
calv
diarrhea
requir
prompt
attent
care
failur
treat
calv
lead
high
level
morbid
mortal
kertz
lundborg
ribeiro
et
al
diarrhea
relat
increas
coliform
bacteria
count
intestin
decreas
lactobacilli
bifidobacteria
count
krehbiel
et
al
ouwehand
et
al
increas
coliform
bacteria
intestin
may
produc
putrefact
substanc
harm
host
fujisawa
et
al
result
gut
microbiota
import
health
develop
host
ng
et
al
rowland
et
al
lactic
acid
bacteria
especi
lactobacillu
bifidobacterium
spp
use
feed
supplement
influenc
gut
microbiota
stimul
immun
respons
host
et
al
bacteria
supplement
like
lactobacillu
rhamnosu
strain
gg
ewaschuk
et
al
lactobacillu
acidophilu
higginbotham
bath
lactobacillu
gasseri
et
al
proven
surviv
gastrointestin
tract
colon
intestin
mucosa
intestin
bacteria
supplement
believ
improv
intestin
microbi
balanc
decreas
adher
pathogen
lumen
intestin
mucosa
affect
mucos
immun
system
isolauri
et
al
ng
et
al
mani
studi
lactic
acid
bacteria
supplement
human
rodent
shown
benefici
effect
intestin
level
decreas
diarrhea
children
rowland
et
al
decreas
increas
number
iga
cell
lamina
propria
perdigon
et
al
reduc
gastric
mucos
inflamm
human
sakamoto
et
al
prevent
gastric
ulcer
rat
uchida
kurakazu
also
aspect
immun
system
influenc
increas
plasma
iga
human
increas
amount
iga
respons
salmonella
typhimurium
inocul
rodent
erickson
hubbard
report
use
supplement
calv
found
promis
result
intestin
microbi
popul
fujisawa
et
al
heinrich
et
al
howev
inform
effect
lactic
acid
bacteria
supplement
immun
prewean
period
need
main
object
studi
evalu
effect
prebiot
supplement
mucos
immun
system
measur
fecal
salivari
iga
evalu
effect
bodi
weight
feed
intak
lymphocyt
count
fecal
bacteria
popul
gener
health
addit
sought
better
understand
role
fecal
salivari
iga
health
dairi
calv
studi
procedur
approv
pennsylvania
state
univers
institut
anim
care
use
committe
twentyeight
holstein
heifer
holstein
bull
calv
univers
herd
randomli
assign
group
treatment
equal
number
heifer
bull
treatment
day
age
calv
remov
dam
within
h
birth
fed
pool
frozen
colostrum
feed
lday
fed
transit
milk
second
third
milk
respect
dam
day
chang
milk
replac
sampl
colostrum
ml
collect
analyz
igg
iga
use
elisa
bethyl
laboratori
inc
montgomeri
tx
usa
use
baselin
calf
igg
iga
analys
calv
vaccin
birth
infecti
bovin
rhinotrach
parainfluenza
intranas
dose
pfizer
anim
health
exton
pa
usa
bovin
rotacoronaviru
oral
dose
calfguard
pfizer
anim
health
exton
pa
usa
blood
sampl
taken
h
measur
igg
statu
calv
hous
opensid
individu
pen
bed
wood
shave
natur
ventil
barn
control
group
fed
commerci
milk
replac
crude
protein
crude
fat
renaiss
nutrit
inc
roar
spring
pa
usa
contain
coccidiostat
deccox
gkg
alpharma
inc
bridgewat
nj
usa
addit
second
group
fed
milk
replac
prebio
support
pb
meiji
feed
co
ltd
tokyo
japan
accord
compani
recommend
gday
contain
ferment
product
l
gasseri
propionibacterium
freudenreichii
addit
pb
began
day
continu
week
g
product
ad
transit
milk
milk
replac
feed
milk
replac
fed
twice
daili
birth
bodi
weight
per
feed
week
calv
fed
day
birth
weight
wean
end
week
fresh
calf
starter
grain
water
offer
ad
libitum
fed
daili
day
age
refus
weigh
weekli
monitor
feed
intak
nutrient
composit
milk
replac
calf
starter
list
tabl
calf
health
monitor
daili
assign
scour
diarrhea
respiratori
gener
appear
score
lesmeist
heinrich
bodi
weight
hip
height
wither
height
heart
girth
measur
day
weekli
blood
sampl
collect
evacu
glass
tube
contain
heparin
week
analysi
lymphocyt
popul
via
flow
cytometri
cell
marker
determin
ohtsuka
et
al
pennsylvania
state
univers
huck
institut
life
scienc
addit
plasma
sampl
obtain
blood
collect
h
week
igg
analysi
use
elisa
bethyl
laboratori
inc
montgomeri
tx
usa
fecal
grab
sampl
collect
rectum
day
gilliland
et
al
hadadji
et
al
rada
petr
saliva
sampl
collect
day
use
small
cotton
ball
place
insid
calf
mouth
reason
wet
min
toyoguchi
et
al
cotton
absorb
saliva
place
syring
compress
recov
liquid
recov
liquid
store
later
analysi
fecal
salivari
sampl
analyz
iga
use
elisa
bethyl
laboratori
montgomeri
tx
usa
statist
analys
conduct
sa
version
sa
institut
inc
cari
nc
usa
mix
procedur
use
model
fix
effect
treatment
time
day
week
interact
random
effect
calf
within
treatment
repeat
measur
time
analyz
use
firstord
autoregress
covari
structur
littel
et
al
close
approxim
normal
distribut
fecal
bacteria
count
transform
log
x
analyz
model
describ
treatment
effect
consid
signific
p
b
trend
identifi
p
b
least
squar
mean
separ
test
tukeykram
adjust
appli
account
multipl
comparison
calv
complet
studi
except
calv
die
trial
one
calv
die
dehydr
treat
correctli
electrolyt
anoth
calf
die
injuri
incur
birth
calv
die
trial
remov
determin
caus
death
result
treatment
sampl
inform
collect
time
particip
trial
includ
result
present
gener
calv
healthi
except
day
age
period
calv
trial
develop
scour
due
cryptosporidium
parvum
endem
low
level
facil
given
electrolyt
treatment
bluelit
c
tech
mix
inc
stewart
mn
usa
day
prevent
measur
addit
calv
control
group
group
pb
requir
antibiot
treatment
naxcel
pfizer
anim
health
exton
pa
usa
day
result
sever
scour
accompani
cryptosporidiosi
major
pathogen
isol
sampl
scour
score
similar
treatment
howev
week
effect
p
b
scour
score
expect
scour
score
exhibit
normal
pattern
increas
week
start
decreas
week
becom
normal
week
treatment
tabl
although
week
treatment
interact
observ
overal
p
individu
mean
compar
differ
detect
treat
calv
analyz
separ
healthi
calv
differ
treatment
bodi
weight
p
valu
healthi
treat
calv
paramet
analyz
treat
calv
elimin
paramet
differ
entir
data
set
analysi
therefor
treat
calv
remain
data
set
analysi
case
pneumonia
trial
respiratori
score
week
control
calv
calv
fed
pb
result
treatment
effect
week
effect
respiratori
score
tabl
gener
appear
score
affect
treatment
week
effect
p
treatment
week
interact
p
due
scour
tabl
total
daili
score
follow
scour
score
show
treatment
effect
week
effect
present
p
b
tabl
intak
igg
iga
colostrum
present
tabl
differ
colostrum
igg
iga
intak
control
pb
group
treatment
effect
plasma
igg
throughout
studi
tabl
howev
week
effect
p
b
igg
decreas
time
lesmeist
heinrich
b
c
valu
within
column
letter
common
indic
signific
effect
time
week
p
b
treatment
effect
detect
treatment
week
interact
signific
overal
scour
gener
appear
score
differ
detect
individu
mean
multipl
comparison
made
tukey
adjust
appli
lymphocyt
popul
time
present
tabl
lymphocyt
popul
demonstr
week
effect
p
affect
treatment
treatment
week
interact
detect
tendenc
toward
interact
treatment
week
overal
p
differ
individu
mean
detect
popul
benefici
bacteria
fece
affect
treatment
condit
experi
howev
pathogen
bacteria
fece
affect
compar
week
calv
pb
treatment
lactobacilli
fece
versu
log
cfug
wet
fece
p
tend
bifidobacteria
versu
log
cfug
wet
fece
p
control
calv
popul
clostridia
log
cfug
wet
fece
pb
control
respect
enterobacteriacea
log
cfug
wet
fece
pb
control
respect
similar
group
bacteria
popul
experi
demonstr
signific
chang
time
p
b
tabl
interact
time
treatment
observ
treatment
effect
overal
fecal
salivari
iga
time
effect
fecal
iga
time
present
fig
salivari
iga
fig
correl
salivari
fecal
iga
r
signific
differ
averag
daili
gain
control
gday
pb
calv
g
day
grain
intak
affect
treatment
kgday
control
calv
kgday
pb
calv
addit
prebio
support
affect
hip
height
wither
height
hearth
girth
total
dri
matter
intak
affect
control
kgday
pb
calv
kgday
howev
tendenc
pb
overal
feed
effici
kg
adgkg
feed
intak
improv
prebiot
addit
control
pb
studi
lactobacilli
bifidobacteria
count
fece
increas
day
day
clostridia
enterobacteria
count
decreas
increas
benefici
bacteria
time
relat
begin
bacteria
popul
intestin
newborn
calf
report
et
al
howev
day
day
lactobacilli
bifidobacteria
count
decreas
clostridia
count
increas
chang
bacteria
probabl
relat
diarrhea
calv
develop
previous
diarrhea
relat
increas
coliform
decreas
lactobacilli
bifidobacteria
count
abutarboush
et
al
higher
count
bifidobacteria
calv
supplement
prebiot
product
found
day
age
fujisawa
et
al
sinc
degre
variabl
clostridia
level
calv
seem
correspond
calv
higher
scour
score
find
may
merit
investig
determin
prebiot
treatment
could
help
decreas
clostridi
colon
intestin
critic
time
gener
pb
increas
lactobacilli
count
tend
increas
bifidobacteria
count
fece
dairi
calv
significantli
decreas
clostridia
enterobacteria
increas
lactobacilli
found
calv
supplement
mix
lactobacilli
week
abutarboush
et
al
l
acidophilu
isol
human
calv
bruce
et
al
howev
previou
studi
product
pb
calv
increas
bifidobacteria
lactobacilli
observ
fujisawa
et
al
effect
lactobacilli
supplement
coliform
posit
trial
other
may
relat
specif
bacteria
use
bruce
et
al
found
decreas
coliform
calv
increas
lactobacilli
found
fujisawa
et
al
abutarboush
et
al
find
decreas
coliform
count
lactic
acid
bacteria
supplement
believ
increas
benefici
bacteria
intestin
decreas
variou
pathogen
howev
bacteria
intestin
could
modifi
mani
factor
diet
diseas
stress
variou
drug
mitsuoka
trial
c
parvum
problem
calv
use
antibiot
necessari
calv
help
recoveri
previou
result
use
supplement
l
acidophilu
wast
milk
find
effect
higginbotham
bath
use
supplement
milk
replac
without
medic
found
posit
result
higginbotham
bath
penicillin
chlortetracyclin
tylosin
tend
inhibit
growth
mix
cultur
bacteria
possibl
could
realiz
potenti
benefit
pb
antibiot
sensit
cephalosporin
higginbotham
bath
possibl
trial
pathogen
decreas
increas
lactobacilli
bifidobacteria
find
effect
pb
health
calv
report
calv
fed
lactic
acid
bacteria
supplement
abe
et
al
higginbotham
bath
howev
report
lactic
acid
bacteria
supplement
decreas
diarrhea
score
week
calv
abutarboush
et
al
later
week
measur
present
studi
supplement
pb
affect
bodi
weight
growth
perform
grain
intak
calv
trial
lack
effect
weight
found
use
differ
type
lactic
acid
bacteria
supplement
et
al
higginbotham
bath
howev
posit
result
found
older
calv
calv
supplement
mixtur
lactic
acid
bacteria
day
higher
bodi
weight
gain
month
age
mokhberdezfouli
et
al
calv
supplement
lactobacilli
bifidobacteria
day
age
higher
weight
day
supplement
abe
et
al
use
pb
increas
benefici
intestin
flora
popul
effect
circul
blood
lymphocyt
report
heinrich
et
al
lymphocyt
increas
slightli
week
week
report
previous
kampen
et
al
valu
report
lower
compar
mean
report
kampen
et
al
fit
within
rang
report
studi
lymphocyt
increas
time
week
group
valu
report
similar
one
report
kampen
et
al
rapid
increas
result
young
anim
expos
first
time
larg
number
environment
antigen
prolifer
matur
b
cell
expect
period
time
kampen
et
al
lymphocyt
increas
week
week
group
valu
report
rang
report
burton
kehrli
calv
around
year
age
lower
report
wilson
et
al
day
reason
differ
valu
like
lymphocyt
valu
vari
greatli
among
individu
anim
age
burton
kehrli
igg
valu
group
decreas
week
week
report
franklin
et
al
expect
colostr
igg
declin
calv
develop
immun
system
supplement
pb
affect
level
plasma
igg
calv
similar
result
found
chicken
supplement
mix
lactobacilli
bifidobacteria
streptococci
haghighi
et
al
howev
calv
supplement
l
acidophilu
l
plantarum
l
acidophilu
week
higher
serum
igg
level
alsaiadi
one
possibl
reason
find
effect
pb
igg
plasma
igg
level
group
week
higher
minimum
recommend
level
mgml
igg
avoid
compromis
surviv
indic
success
passiv
immun
transfer
valu
still
high
week
like
calv
immun
system
function
week
age
increas
benefici
bacteria
effect
product
iga
fece
saliva
fecal
iga
decreas
day
day
increas
day
decreas
day
high
level
iga
fece
day
like
reflect
iga
obtain
matern
colostrum
resecret
iga
back
intestin
origin
colostrum
could
determin
studi
declin
iga
level
reflect
decreas
iga
colostrum
ingest
howev
day
calv
start
develop
diarrhea
iga
level
increas
increas
iga
like
cellular
respons
onset
diarrhea
day
level
decreas
like
due
less
intestin
stress
enter
damag
heal
infect
clear
salivari
iga
valu
increas
age
treatment
increas
time
report
human
jafarzadeh
et
al
although
statist
signific
day
pb
calv
higher
level
saliva
iga
increas
day
compar
decreas
day
control
decreas
saliva
iga
level
indic
stress
diseas
report
dog
human
kikkawa
et
al
supplement
pb
milk
replac
increas
benefici
bacteria
fece
first
day
life
howev
increas
decreas
coliform
bacteria
affect
observ
health
calv
presenc
c
parvum
calv
time
trial
could
affect
observ
health
growth
calv
growth
differ
howev
feed
effici
tend
improv
pb
calv
iga
saliva
good
measur
immun
calv
iga
fece
appear
good
measur
mucos
immun
studi
need
influenc
iga
fece
develop
new
method
measur
immun
calv
first
day
life
suscept
diseas
death
